Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharm Biomed Anal ; 28(2): 295-302, 2002 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-11929672

RESUMO

Peripheral vascular disease is a common ailment of the aged and diabetic communities. As the numbers of these individuals increase, the need for therapeutic interventions will continue to grow. One of the possible therapies is the use of prostaglandins (PGE(1), prostacyclin and Iloprost) to decrease the vascular tone and increase vascular blood flow. Due to the hydrophobicity of the prostaglandins and prostaglandin analogues, various vehicles have been utilized to maintain the active pharmaceutical ingredient in a stable solution, e.g. alpha-cyclodextrin (Alprostadil, Edex) or emulsified lipid vehicles. In our laboratory, we designed a method for separating and assaying lipid-encapsulated PGE(1). Utilizing organic extraction, automated solid-phase extraction and precipitation techniques, we validated the measurement of the PGE(1) and PGA(1) content of the clinical drug formulation in the microgram per milliliter concentration range with an high performance liquid chromatography (HPLC) assay.


Assuntos
Alprostadil/análise , Antivirais/análise , Prostaglandinas A/análise , Alprostadil/administração & dosagem , Antivirais/administração & dosagem , Autoanálise , Soluções Tampão , Cromatografia Líquida de Alta Pressão , Injeções Intravenosas , Lipossomos , Prostaglandinas A/administração & dosagem , Padrões de Referência , Reprodutibilidade dos Testes , Solventes , Espectrofotometria Ultravioleta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...